Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EDN0 | ISIN: US01643A3068 | Ticker-Symbol: AWJ
München
09.02.24
17:21 Uhr
0,050 Euro
+0,012
+29,87 %
Branche
Getränke/Tabak
Aktienmarkt
Sonstige
1-Jahres-Chart
ALKALINE WATER COMPANY INC Chart 1 Jahr
5-Tage-Chart
ALKALINE WATER COMPANY INC 5-Tage-Chart
GlobeNewswire (Europe)
105 Leser
Artikel bewerten:
(0)

The Alkaline Water Company, Inc.: The Alkaline Water Company CEO Issues Open Letter to Shareholders on Progress Within Two Distinct Growth Opportunities

Finanznachrichten News

SCOTTSDALE, Ariz., Dec. 11, 2024 (GLOBE NEWSWIRE) -- The Alkaline Water Company, Inc. (OTC: WTER), today issued an open letter from Ricky Wright, Chief Executive Officer, to shareholders discussing the Company's progress to date with the advancement of the business model and the future plans for WTER. The full letter is published below:

Dear Shareholders,

I am excited to address our valued shareholders as I return to The Alkaline Water Company. From 2012 through 2022, we successfully established alkaline water as a recognized beverage category. Today, I am eager to share our path forward in this thriving billion-dollar market.

The alkaline water market offers two distinct growth opportunities: pH-enhanced purified water and naturally alkaline spring waters. Both segments are experiencing strong consumer demand and remain highly fragmented. This fragmentation presents a unique opportunity for strategic consolidation and significant growth.

Our immediate strategic initiatives include:

1. Co-Packing Network Development

We have initiated discussions with strategic co-packing partners nationwide. These relationships were built during our previous growth phase. The facilities are located near key markets. They are capable of bottling Alkaline Water across all formats, from single-serve to multi-gallon packages.

2. Market Position Enhancement

We are preparing to file our Form 211 application with FINRA with an appropriate market maker. This will establish eligibility for proprietary broker-dealer quotations and continuous market making. This crucial step will enhance our ability to execute strategic acquisitions.

3. Distribution Network Rebuilding

We are reconnecting with our established network of suppliers, brokers, and distributors. Their industry expertise and market reach will help us rebuild our presence across all trade channels.

Under my previous leadership, we expanded to over 75,000 stores nationwide. We became the largest independent enhanced water company in the country. The time away has provided valuable perspective on our achievements and areas for improvement. These insights position us well for our next growth phase.

The country's increasing focus on health and wellness creates the perfect environment for our return. We understand this market. We know how to build brands. Most importantly, we know how to create value in this industry. Our mission remains clear - to provide consumers with premium water products that contribute to their wellness journey.

We have overcome the hurdles in the past and I am deeply committed to rebuilding The Alkaline Water Company into an industry leader. With your support. We look forward to sharing our progress.

Sincerely,

Ricky Wright

President and CEO

The Alkaline Water Company, Inc.

Disclaimer Regarding Forward Looking Statements

Certain statements that we make may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning future strategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as "believes," "expects," "anticipates," "intends," "plans," "estimates," "projects," "forecasts," and future or conditional verbs such as "will," "may," "could," "should," and "would," as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties, and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-looking statements.

About The Alkaline Water Company, Inc.

The Alkaline Water Company, Inc., are the developers of Alkaline - a purified alkaline water, enhanced with Himalayan rock salt and engineered for a smooth and delicious taste.

Company contact:

5524 North 51st Avenue

Glendale, Arizona 85301

Telephone: (877)-255-9837

Website: www.thealkalinewaterco.com

Email: info@thealkalinewaterco.com

Source: The Alkaline Water Company, Inc


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.